@prefix this: . @prefix sub: . @prefix np: . @prefix pav: . @prefix rdf: . @prefix infores: . @prefix xsd: . @prefix umls: . @prefix orcid: . @prefix rdfs: . @prefix biolink: . @prefix prov: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo; a np:Nanopublication . } sub:assertion { a biolink:ChemicalEntity; rdfs:label "CAMZYOS"; biolink:category biolink:ChemicalEntity . umls:C0263630 a biolink:DiseaseOrPhenotypicFeature; rdfs:label "hypertrophic"; biolink:category biolink:DiseaseOrPhenotypicFeature . a biolink:ChemicalEntity; rdfs:label "™"; biolink:category biolink:ChemicalEntity . a biolink:DiseaseOrPhenotypicFeature; rdfs:label "HCM"; biolink:category biolink:DiseaseOrPhenotypicFeature . a biolink:DiseaseOrPhenotypicFeature; rdfs:label "obstructive hypertrophic cardiomyopathy"; biolink:category biolink:DiseaseOrPhenotypicFeature . sub:_1 rdf:object ; rdf:predicate biolink:treats; rdf:subject ; a biolink:Association; biolink:aggregator_knowledge_source infores:knowledge-collaboratory; biolink:category biolink:Association; biolink:publications . sub:_2 rdf:object ; rdf:predicate biolink:treats; rdf:subject ; a biolink:Association; biolink:aggregator_knowledge_source infores:knowledge-collaboratory; biolink:category biolink:Association; biolink:publications . sub:_3 rdf:object ; rdf:predicate biolink:treats; rdf:subject ; a biolink:Association; biolink:aggregator_knowledge_source infores:knowledge-collaboratory; biolink:category biolink:Association; biolink:publications . sub:_4 rdf:object ; rdf:predicate biolink:treats; rdf:subject ; a biolink:Association; biolink:aggregator_knowledge_source infores:knowledge-collaboratory; biolink:category biolink:Association; biolink:publications . sub:_5 rdf:object umls:C0263630; rdf:predicate biolink:treats; rdf:subject ; a biolink:Association; biolink:aggregator_knowledge_source infores:knowledge-collaboratory; biolink:category biolink:Association; biolink:publications . sub:_6 rdf:object umls:C0263630; rdf:predicate biolink:treats; rdf:subject ; a biolink:Association; biolink:aggregator_knowledge_source infores:knowledge-collaboratory; biolink:category biolink:Association; biolink:publications . } sub:provenance { sub:assertion prov:generatedAtTime "2022-10-11T09:30:02.005341"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0002-3668-2627; prov:wasQuotedFrom "CAMZYOS™ is indicated for the treatment of adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (HCM) to improve functional capacity and symptoms. CAMYOS was indicated for adults with. symptomatic. New York. Heart Association class II and III obstructive. hypertrophic. hypertrophrophyopathy." . biolink: pav:version "2.3.0" . } sub:pubInfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEApdULbl+/+pkVlq0fAzWmzfgIb+XMuQPKHMDVzUTWCZBjLfzORll42ptr52e4w7tTYkUKrBsQbx8lkjZWAlWiyh+xIK0oLFSdYRSt63kgiyRYBUOR+spcgmofb7f6JyftArPVTKhsWOMt/mcyNG9qc3lw8B/xuPmLteUWO33xWhfXQreTw1lsGUkZ1j4cB4X9HIuI20ktLYLCXaBauNHEJZ4qp6/Q2ATsJcw8tg7aRmFKXhrjM9maZ2+0cMg0Jpmn2UnDlPKXEA6Qq+qnvvQt8KFjIzP9FTMyvrWl8tTd0NCmS9VpooZJQ8We1lGMPXg5bMbe/bVkTf70fbFMf0RKrQIDAQAB"; npx:hasSignature "fegq/Asx9Gi6GG7pCrJBqW0MC9cTCOH4fT5NT7jDSuFyvzRs6XKaK9WC9QZVmyJ1XQyW5/0QnJmFVAcENdP1GnPe5HKQ/tEOS6+scC4oE6gzsV8GxPWKbSJPAtjNJMlKsB3M6CsIl7TVvWZ4MiDzWxX5dfUc/llMouUkoTozTdkbSFzp17ZrFcl0q1HVaQ4ndh+pDWZz/PD4rKbAOZNidWgvfzYwcJoVUJQ52Lxrg8UQwXJmyU5UMTRoj44uEVkn3u9wieW+Su4oeRIC/cN22grfD0Km6kGEsz3Anmw4MamF9t/qo3kmJgt0RVpPcZKKBjc2a/l3K7ffBd/I8A6X0A=="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2022-10-11T09:30:02.005341"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0002-3668-2627 . }